![](/img/cover-not-exists.png)
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Dalgleish, Angus G, Stebbing, Justin, Adamson, Douglas J A, Arif, Seema Safia, Bidoli, Paolo, Chang, David, Cheeseman, Sue, Diaz-Beveridge, Robert, Fernandez-Martos, Carlos, Glynne-Jones, Rob, GranettVolume:
115
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2016.342
Date:
October, 2016
File:
PDF, 51 KB
english, 2016